Mankind Pharma Limited (NSE:MANKIND)

Mankind Pharma Statistics

Total Valuation

Mankind Pharma has a market cap or net worth of INR 1.01 trillion. The enterprise value is 1.07 trillion.

Market Cap	1.01T
Enterprise Value	1.07T

Important Dates

The next estimated earnings date is Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	Aug 8, 2025

Share Statistics

Mankind Pharma has 412.76 million shares outstanding. The number of shares has increased by 1.63% in one year.

Current Share Class	412.76M
Shares Outstanding	412.76M
Shares Change (YoY)	+1.63%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	57.72%
Owned by Institutions (%)	19.76%
Float	106.26M

Valuation Ratios

The trailing PE ratio is 52.65 and the forward PE ratio is 44.93. Mankind Pharma's PEG ratio is 2.50.

PE Ratio	52.65
Forward PE	44.93
PS Ratio	7.81
PB Ratio	6.92
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	2.50

Enterprise Valuation

EV / Earnings	56.58
EV / Sales	8.30
EV / EBITDA	34.25
EV / EBIT	43.22
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.58
Debt / EBITDA	2.73
Debt / FCF	n/a
Interest Coverage	4.25

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	9.38%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	4.79M
Profits Per Employee	701,605
Employee Count	26,978
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Mankind Pharma has paid 4.83 billion in taxes.

Income Tax	4.83B
Effective Tax Rate	20.15%

Stock Price Statistics

The stock price has increased by +0.16% in the last 52 weeks. The beta is 0.26, so Mankind Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	+0.16%
50-Day Moving Average	2,510.35
200-Day Moving Average	2,466.89
Relative Strength Index (RSI)	42.38
Average Volume (20 Days)	297,234

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mankind Pharma had revenue of INR 129.10 billion and earned 18.93 billion in profits. Earnings per share was 46.42.

Revenue	129.10B
Gross Profit	90.06B
Operating Income	24.66B
Pretax Income	23.95B
Net Income	18.93B
EBITDA	31.03B
EBIT	24.66B
Earnings Per Share (EPS)	46.42

Balance Sheet

The company has 25.25 billion in cash and 85.11 billion in debt, giving a net cash position of -59.87 billion or -145.04 per share.

Cash & Cash Equivalents	25.25B
Total Debt	85.11B
Net Cash	-59.87B
Net Cash Per Share	-145.04
Equity (Book Value)	145.68B
Book Value Per Share	347.39
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 69.76%, with operating and profit margins of 19.10% and 14.66%.

Gross Margin	69.76%
Operating Margin	19.10%
Pretax Margin	18.56%
Profit Margin	14.66%
EBITDA Margin	24.04%
EBIT Margin	19.10%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.08%.

Dividend Per Share	2.00
Dividend Yield	0.08%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.63%
Shareholder Yield	-1.55%
Earnings Yield	1.88%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2